![Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial - Piraccini - 2022 - Journal of the European Academy of Dermatology and Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial - Piraccini - 2022 - Journal of the European Academy of Dermatology and](https://onlinelibrary.wiley.com/cms/asset/09b6a978-5584-4af8-a475-3328285a8702/jdv17738-fig-0001-m.jpg)
Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial - Piraccini - 2022 - Journal of the European Academy of Dermatology and
![Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients - Hu - 2015 - Dermatologic Therapy - Wiley Online Library Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients - Hu - 2015 - Dermatologic Therapy - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/64716430-384e-4bb2-b464-91f8c5d375b6/dth12246-fig-0002-m.jpg)
Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients - Hu - 2015 - Dermatologic Therapy - Wiley Online Library
![Pharmaceutics | Free Full-Text | Optimization and Transfollicular Delivery of Finasteride-Loaded Proniosomes for Hair Growth Stimulation in C57BL/6Mlac Mice Pharmaceutics | Free Full-Text | Optimization and Transfollicular Delivery of Finasteride-Loaded Proniosomes for Hair Growth Stimulation in C57BL/6Mlac Mice](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-13-02177/article_deploy/html/images/pharmaceutics-13-02177-g008.png?1639725917)
Pharmaceutics | Free Full-Text | Optimization and Transfollicular Delivery of Finasteride-Loaded Proniosomes for Hair Growth Stimulation in C57BL/6Mlac Mice
![Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study | SpringerLink Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40257-018-0387-0/MediaObjects/40257_2018_387_Fig5_HTML.jpg)
Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study | SpringerLink
![The Lifelong Duration of Finasteride and Minoxidil Hair Loss Treatment, and a One-Time Alternative - YouTube The Lifelong Duration of Finasteride and Minoxidil Hair Loss Treatment, and a One-Time Alternative - YouTube](https://i.ytimg.com/vi/nuYeYeci9i4/mqdefault.jpg)
The Lifelong Duration of Finasteride and Minoxidil Hair Loss Treatment, and a One-Time Alternative - YouTube
![A randomized, double‐blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia - A randomized, double‐blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia -](https://onlinelibrary.wiley.com/cms/asset/0e7d4471-393f-4c6f-b1cb-a0531b61b2d9/jdv15171-fig-0003-m.jpg)
A randomized, double‐blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia -
![Placebo‐controlled dose‐effect studies with topical minoxidil 2% or 5% in male‐patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol - Van Neste - 2020 - Skin Research Placebo‐controlled dose‐effect studies with topical minoxidil 2% or 5% in male‐patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol - Van Neste - 2020 - Skin Research](https://onlinelibrary.wiley.com/cms/asset/5134f214-c1ef-45f6-9e48-7b707e9c328b/srt12827-fig-0001-m.jpg)